China Resources Pharmaceutical Group's (HKG:3320) subsidiary Dong-E-E-Jiao expects to record a profit attributable to its shareholders between 1.10 billion yuan and 1.18 billion yuan for the nine months ended Sept. 30, 40% to 50% higher than 783.7 million yuan logged for the same period last year, a Wednesday filing with the Hong Kong Exchange said.
The company attributed the increase in profit to Dong-E-E-Jiao's consumer-centered approach, integrating marketing with digital placement and adoption of a "dual-wheel drive" growth model.
The pharmaceutical and healthcare products company's shares closed nearly 4% lower on Wednesday.
Price (HKD): $5.93, Change: $-0.22, Percent Change: -3.58%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。